Apolipoprotein AI (ApoA-I), immunity, inflammation and cancer

K Georgila, D Vyrla, E Drakos - Cancers, 2019 - mdpi.com
Apolipoprotein AI (ApoA-I), the major protein component of high-density lipoproteins (HDL)
is a multifunctional protein, involved in cholesterol traffic and inflammatory and immune …

Electrical biosensors and the label free detection of protein disease biomarkers

X Luo, JJ Davis - Chemical Society Reviews, 2013 - pubs.rsc.org
Electrical detection methodologies are likely to underpin the progressive drive towards
miniaturised, sensitive and portable biomarker detection protocols. In being easily integrated …

Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer

Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai… - Cancer research, 2004 - AACR
Early detection remains the most promising approach to improve long-term survival of
patients with ovarian cancer. In a five-center case-control study, serum proteomic …

Human body fluid proteome analysis

S Hu, JA Loo, DT Wong - Proteomics, 2006 - Wiley Online Library
The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

Label and label-free detection techniques for protein microarrays

A Syahir, K Usui, K Tomizaki, K Kajikawa, H Mihara - Microarrays, 2015 - mdpi.com
Protein microarray technology has gone through numerous innovative developments in
recent decades. In this review, we focus on the development of protein detection methods …

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

EP Diamandis - Molecular & Cellular Proteomics, 2004 - ASBMB
Serum proteomic profiling, by using surfaced-enhanced laser desorption/ionization-time-of-
flight mass spectrometry, is one of the most promising new approaches for cancer …

Serum protein markers for early detection of ovarian cancer

G Mor, I Visintin, Y Lai, H Zhao… - Proceedings of the …, 2005 - National Acad Sciences
Early diagnosis of epithelial ovarian cancer (EOC) would significantly decrease the
morbidity and mortality from this disease but is difficult in the absence of physical symptoms …

Multiplexed immunophenoty** of circulating exosomes on nano-engineered ExoProfile chip towards early diagnosis of cancer

P Zhang, X Zhou, Y Zeng - Chemical science, 2019 - pubs.rsc.org
Circulating exosomes have been studied as a promising biomarker for non-invasive cancer
diagnosis, as they are implicated in tumor initiation, progression, and metastasis. However …

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence

LJ Havrilesky, CM Whitehead, JM Rubatt, RL Cheek… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: To determine the utility of novel combinations of biomarkers, using both a one-
step and two-step assay format, to distinguish serum of early ovarian cancer patients from …

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

V Nossov, M Amneus, F Su, J Lang, JMT Janco… - American journal of …, 2008 - Elsevier
Ovarian cancer is the leading cause of death from gynecologic malignancy in the United
States. More than 80% of patients present with advanced disease, with 5 year survival rates …